https://www.selleckchem.com/pr....oducts/jak-inhibitor
eveloped to predict the OS of ICCA patients. LT might be considered as a potential option for some ICCA patients.IgA nephropathy (IgAN) is a common form of primary glomerulonephritis and its main pathological changes are mesangial cell proliferation and matrix expansion. Autophagy inhibition may result in its mesangial cell proliferation and renal lesions. SUMOylation is a eukaryotic-reversible post-translational modification where SUMO is covalently attached to target proteins to regulate their properties. It is largely unclear
Like
Comment
Share
